Cosmos Health Inc. Earnings Per Share Disclosure
NOTE 16 – EARNINGS PER SHARE
Basic net loss per share is computed by dividing net loss attributable to the common stockholders, decreased with respect to net income or increased with respect to net loss by dividends declared on preferred stock by using the weighted-average number of common shares outstanding. The dilutive effect of incremental common shares potentially issuable under outstanding options, warrants and restricted shares is included in diluted earnings per share in 2025 and 2024 utilizing the treasury stock method. The computations of basic and diluted per share data were as follows:
|
| 2025 |
|
| 2024 |
| ||
Numerator for Basic and Diluted Earnings Per Share: |
|
|
|
|
|
| ||
Net loss attributable to common stockholders |
| $ | (19,144,998 | ) |
| $ | (22,378,042 | ) |
Denominator for Basic Earnings Per Share: |
|
|
|
|
|
|
|
|
Weighted Average Shares |
|
| 30,289,072 |
|
|
| 19,147,726 |
|
Potentially Dilutive Common Shares |
|
|
|
|
|
|
|
|
Adjusted Weighted Average Shares |
|
| 30,289,072 |
|
|
| 19,147,726 |
|
Basic and Diluted Net Loss per Share |
|
| (0.63 | ) |
|
| (1.17 | ) |
The following table summarized the potential shares of common stock that were excluded from the computation of diluted net loss per share for the years ended December 31, 2025 and 2024 as such shares would have had an anti-dilutive effect:
|
| 2025 |
|
| 2024 |
| ||
Common Stock Warrants |
|
| 12,926,507 |
|
|
| 12,926,507 |
|
Common Stock Options |
|
| - |
|
|
| - |
|
Convertible Debt |
|
| 20,285,525 |
|
|
| - |
|
Total |
|
| 33,212,032 |
|
|
| 12,926,507 |
|
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Apr 15, 2026 | Showing above |
| 2024 | Apr 15, 2025 | |
| 2022 | Apr 12, 2023 | |
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.